Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.47 CAD | -10.83% | +3.35% | +488.10% |
Sales 2024 * | - | Sales 2025 * | 438K 320K | Capitalization | 207M 151M |
---|---|---|---|---|---|
Net income 2024 * | -15M -10.96M | Net income 2025 * | -19M -13.89M | EV / Sales 2024 * | - |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 473 x |
P/E ratio 2024 * |
-12.2
x | P/E ratio 2025 * |
-10.5
x | Employees | 16 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 71.81% |
Latest transcript on Medicenna Therapeutics Corp.
1 day | +5.73% | ||
1 week | +16.39% | ||
Current month | +19.40% | ||
1 month | +84.67% | ||
3 months | +412.96% | ||
6 months | +403.64% | ||
Current year | +559.52% |
Managers | Title | Age | Since |
---|---|---|---|
Founder | - | 11-09-30 | |
Fahar Merchant
CEO | Chief Executive Officer | - | 15-02-01 |
David Hyman
DFI | Director of Finance/CFO | - | Feb. 13 |
Members of the board | Title | Age | Since |
---|---|---|---|
Karen Dawes
BRD | Director/Board Member | 72 | 19-09-23 |
Albert Beraldo
BRD | Director/Board Member | - | 16-11-21 |
Fahar Merchant
CEO | Chief Executive Officer | - | 15-02-01 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-10 | 2.47 | -10.83% | 174 458 |
24-05-09 | 2.77 | +5.73% | 81,330 |
24-05-08 | 2.62 | -7.09% | 121,811 |
24-05-07 | 2.82 | +15.57% | 163,945 |
24-05-06 | 2.44 | +2.09% | 95,461 |
Delayed Quote Toronto S.E., May 09, 2024 at 03:59 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+559.52% | 151M | |
+23.37% | 47.02B | |
+49.79% | 41.86B | |
-0.94% | 41.76B | |
-4.32% | 28.8B | |
+11.29% | 26.05B | |
-20.92% | 19.15B | |
+3.20% | 12.55B | |
-2.67% | 11.82B | |
+30.23% | 12.34B |
- Stock Market
- Equities
- MDNA Stock